Emerging drugs for ophthalmic diseases.

about

Tissue factor knockdown in porcine islets: an effective approach to suppressing the instant blood-mediated inflammatory reaction.Discovery of Novel N-Substituted Prolinamido Indazoles as Potent Rho Kinase Inhibitors and Vasorelaxation Agents.

P2860

Q45870866-2BDCD76F-CB54-436A-A2E7-4FF89CDDD9F3 Q50094639-AB6AD038-7E6B-46F5-BF07-5C0D3F3762C2

P2860

Emerging drugs for ophthalmic diseases.

Item

http://www.wikidata.org/entity/Q35581180

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Emerging drugs for ophthalmic diseases.

@ast

Emerging drugs for ophthalmic diseases.

@en

type

Item

label

Emerging drugs for ophthalmic diseases.

@ast

Emerging drugs for ophthalmic diseases.

@en

prefLabel

Emerging drugs for ophthalmic diseases.

@ast

Emerging drugs for ophthalmic diseases.

@en

P1476

Emerging drugs for ophthalmic diseases

@en

P2093

Gary D Novack

http://www.w3.org/2001/XMLSchema#string

P2860

Myopia.

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections

A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.

Lutetium texaphyrin (Lu-Tex): a potential new agent for ocular fundus angiography and photodynamic therapy.

Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.

Topically applied betaxolol attenuates ischaemia-induced effects to the rat retina and stimulates BDNF mRNA.

Prevalence and 15-year incidence of retinopathy and associated characteristics in middle-aged and elderly diabetic men.

Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate.

Drusen proteome analysis: an approach to the etiology of age-related macular degeneration.

P304

251-266

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728214.8.1.251

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gary D. Novack

P577

2003-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14610925

http://www.w3.org/2001/XMLSchema#string

Emerging drugs for ophthalmic diseases.

about

P2860

P2860

Emerging drugs for ophthalmic diseases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698